Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,977 | -13,198 | -7,002 | -10,796 | -19,423 |
| Depreciation Amortization | 1 | 1 | 1 | 1 | 55 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -94 |
| Other Working Capital | 316 | 386 | -794 | -1,173 | 1,465 |
| Other Operating Activity | 1,168 | 5,889 | 989 | 782 | 6,048 |
| Operating Cash Flow | $-6,493 | $-6,922 | $-6,807 | $-11,186 | $-11,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 150 | N/A | N/A | N/A | -65 |
| Net Acquisitions | N/A | N/A | 1,500 | N/A | 31 |
| Investing Cash Flow | $150 | $N/A | $1,500 | $N/A | $-34 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 11,750 |
| Common Stock Issued | 8,473 | 7,846 | 4,134 | 9,126 | 1,895 |
| Common Stock Repurchased | N/A | N/A | -2 | N/A | N/A |
| Financing Cash Flow | $8,473 | $7,846 | $4,132 | $9,126 | $13,645 |
| Beginning Cash Position | 3,751 | 2,827 | 4,002 | 6,062 | 4,401 |
| End Cash Position | 5,881 | 3,751 | 2,827 | 4,002 | 6,062 |
| Net Cash Flow | $2,131 | $923 | $-1,175 | $-2,060 | $1,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,493 | -6,922 | -6,807 | -11,186 | -11,949 |
| Capital Expenditure | 150 | N/A | N/A | N/A | -65 |
| Free Cash Flow | -6,343 | -6,922 | -6,807 | -11,186 | -12,014 |